| Line item | 2026-03-31 FY | 2025-03-31 FY | 2024-03-31 FY | 2023-03-31 FY |
|---|---|---|---|---|
| Revenue | – | – | – | – |
| Cost of Revenue | – | – | – | – |
| Gross Profit | – | – | – | – |
| Operating Expenses | $139.92K | $130.83K | $266.58K | $175.51K |
| R&D | – | – | – | – |
| SG&A | $73.77K | $73.09K | $73.74K | $75.47K |
| Operating Income | -$139.92K | -$130.83K | -$266.58K | -$175.51K |
| Interest Expense | $0.00 | – | – | – |
| Tax Expense | – | – | – | – |
| Net Income | -$139.92K | -$130.83K | -$202.09K | -$120.73K |
| EPS (basic) | – | -0.0100 | -0.0100 | 0.0000 |
| EPS (diluted) | -0.0100 | -0.0100 | -0.0100 | 0.0000 |
| Shares (diluted) | $59.64M | $59.64M | $58.88M | $53.51M |